Eagle Pharmaceuticals
EGRX
#10414
Rank
S$4.19 M
Marketcap
S$0.32
Share price
0.00%
Change (1 day)
-80.27%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: S$4.19 Million

As of March 2026 Eagle Pharmaceuticals has a market cap of S$4.19 Million. This makes Eagle Pharmaceuticals the world's 10414th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026S$4.19 M-43.98%
2025S$7.48 M-22.72%
2024S$9.68 M-89.2%
2023S$89.7 M-82.41%
2022S$0.51 B-42.63%
2021S$0.88 B10.74%
2020S$0.80 B-27.29%
2019S$1.10 B44.16%
2018S$0.76 B-28.17%
2017S$1.06 B-40.01%
2016S$1.77 B-9.39%
2015S$1.96 B582.2%
2014S$0.28 B

End of Day market cap according to different sources

On Mar 3rd, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
S$4.19 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$753.75 B 17,971,274.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$407.06 B 9,705,248.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$1.145 T 27,306,316.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$260.69 B 6,215,408.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$161.84 B 3,858,776.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$146.43 B 3,491,315.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$48.87 B 1,165,109.41%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel